3842 |
Miller W.C., Hoffman I.F., Hanscom B.S., Ha T.V., Dumchev K., Djoerban Z., Rose S.M., Latkin C.A., Metzger D.S., Lancaster K.E., Go V.F., Dvoriak S., Mollan K.R., Reifeis S.A., Piwowar-Manning E.M., Richardson P., Hudgens M.G., Hamilton E.L., Sugarman J., Eshleman S.H., Susami H., Chu V.A., Djauzi S., Kiriazova T., Bui D.D., Strathdee S.A., Burns D.N. |
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study |
2018 |
The Lancet |
63 |
Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, United States; Division of Infectious Diseases, School of Medicine, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Center for AIDS Research, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, United States; UNC Vietnam, Yen Hoa, Cau Giay District, Hanoi, Viet Nam; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Science Facilitation Department, FHI 360, Durham, NC, United States; Department of Health Policy and Management, Johns Hopkins University, Baltimore, MA, United States; Berman Institute of Bioethics and Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MA, United States; Bloomberg School of Public Health and Department of Pathology, Johns Hopkins University, Baltimore, MA, United States; HIV Prevention Research Division, Department of Psychiatry, School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Academy of Labor, Social Relations and Tourism, Kyiv, Ukraine; Vietnam Administration of HIV/AIDS Control, Hanoi, Viet Nam; Department of Medicine, School of Medicine, University of California San Diego, La Jolla, CA, United States; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MA, United States |
National Institutes of Health; National Institute of Mental Health; National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; School of Arts and Sciences, University of Pennsylvania; Center for AIDS Research, University of North Carolina at Chapel Hill |
Lancet Publishing Group |
Q1 |
|
|